Inventor · disambiguated record
Cindy Castado
Also filed as: CASTADO CINDY
14 granted patents·17 pending applications·53 citations·filing 2002–2021
91Inventor score
Top patents by PatentIndex Score
31 records- 0194US10093722B2Nucleotide sequences, vectors and host cellsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted Oct 9, 2018·8 cites·24 claims
- 0293US10377816B2Nucleotide sequences, vectors and host cellsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Aug 13, 2019·7 cites·11 claims
- 0391US9644024B2Nucleotide sequences, vectors and host cellsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Granted May 9, 2017·4 cites·14 claims
- 0488US9409974B2Immunogenic compositionCASTADO CINDY·Filed 2012·Granted Aug 9, 2016·6 cites·12 claims
- 0588US9290565B2Immunogenic compositionCASTADO CINDY·Filed 2012·Granted Mar 22, 2016·6 cites·3 claims
- 0681US10548963B2Immunogenic composition for use in vaccination against staphylococciGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Feb 4, 2020·4 cites·9 claims
- 0780US9669083B2Immunogenic composition comprising elements of C. difficile CDTb and/or CDTa proteinsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2013·Granted Jun 6, 2017·4 cites·14 claims
- 0870US10947280B2UspA2 protein constructs and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Granted Mar 16, 2021·0 cites·12 claims
- 0970US10040832B2UspA2 protein constructs and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Granted Aug 7, 2018·1 cites·28 claims
- 1069US10745449B2UspA2 protein constructs and uses thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Aug 18, 2020·0 cites·22 claims
- 1169US8574596B2Pertussis antigens and use thereof in vaccinationCASTADO CINDY·Filed 2004·Granted Nov 5, 2013·13 cites·13 claims
- 1265US2020179504A1Immunogenic composition for use in vaccination against staphylococciGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Application pending·0 cites
- 1360US2008311146A1Immunogenic CompositionGLAXOSMITHKLINE BIOLOG SA·Filed 2006·Application pending·0 cites
- 1452US2008095777A1Immunogenic Composition for Use in Vaccination Against StaphylococceiGLAXOSMITHKLINE BIOLOG SA·Filed 2005·Application pending·0 cites
- 1551US2023293659A1Truncated fusobacterium nucleatum fusobacterium adhesin a (fada) protein and immunogenic compositions thereofGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Application pending·0 cites
- 1651US2008085289A1Immunogenic CompositionCASTADO CINDY·Filed 2005·Application pending·0 cites
- 1748US2011008385A1Immunogenic compositionGLAXOSMITHKLINE BIOLOG SA·Filed 2010·Application pending·0 cites
- 1848US2021220462A1Immunogenic proteins and compositionsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2019·Application pending·0 cites
- 1948US2015328302A1Immunogenic composition for use in vaccination against staphylococceiGLAXOSMITHKLINE BIOLOG SA·Filed 2015·Application pending·0 cites
- 2047US2018043005A1Immunogenic composition comprising elements of c. difficile cdtb and/or cdta proteinsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 2147US2004241687A1Novel compoundsFiled 2002·Application pending·0 cites
- 2246US9567377B2Immunogenic compositionPOOLMAN JAN·Filed 2011·Granted Feb 14, 2017·0 cites·4 claims
- 2346US2015125481A1Immunogenic CompositionGLAXOSMITHKLINE BIOLOG SA·Filed 2015·Application pending·0 cites
- 2446US2022273789A1Therapeutic viral vaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2020·Application pending·0 cites
- 2545US2005118659A1Novel compoundsFiled 2002·Application pending·0 cites
- 2643US2017209562A1Immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2016·Application pending·0 cites
- 2741US11266733B2Viral antigensGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Mar 8, 2022·0 cites·19 claims
- 2840US2017290905A1VaccineGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Application pending·0 cites
- 2939US11466292B2Compositions and methods of treatmentGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Oct 11, 2022·0 cites·20 claims
- 3034US2017218031A1Clostridium difficile immunogenic compositionGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2015·Application pending·0 cites
- 3129US2012141523A1Immunogenic composition comprising antigenic s. aureus proteinsCASTADO CINDY·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →